Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sévenet N"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł :
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Autorzy :
Leman R; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Gaildrat P; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Le Gac G; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Ka C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Fichou Y; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Audrezet MP; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Caux-Moncoutier V; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Caputo SM; Service de Génétique, Institut Curie, 75005 Paris, France.
Boutry-Kryza N; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Léone M; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Mazoyer S; Lyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, 69008 Lyon, France.
Bonnet-Dorion F; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Sevenet N; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Guillaud-Bataille M; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Rouleau E; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Bressac-de Paillerets B; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Wappenschmidt B; Division of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, 50937 Cologne, Germany.
Rossing M; Centre for Genomic Medicine, Rigshospitalet, University of Copenhagen, 1017 Copenhagen, Denmark.
Muller D; Laboratoire d'Oncogénétique, Centre Paul Strauss, 67000 Strasbourg, France.
Bourdon V; Laboratoire d'Oncogénétique Moléculaire, Institut Paoli-Calmettes, 13009 Marseille, France.
Revillon F; Laboratoire d'Oncogénétique Moléculaire Humaine, Centre Oscar Lambret, 59000 Lille, France.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Rousselin A; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Davy G; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castelain G; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castéra L; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Sokolowska J; Service de Génétique, CHU Nancy, 54035 Nancy, France.
Coulet F; Service de génétique, Hôpital Pitié Salpétrière, AP-HP, 75013 Paris, France.
Delnatte C; Laboratoire de génétique moléculaire, CHU Nantes, 44000 Nantes, France.
Férec C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Martins A; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Krieger S; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Houdayer C; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Feb 20; Vol. 48 (3), pp. 1600-1601.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Corrigendum: Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Autorzy :
Leman R; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Gaildrat P; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Gac GL; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Ka C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Fichou Y; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Audrezet MP; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Caux-Moncoutier V; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Caputo SM; Service de Génétique, Institut Curie, 75005 Paris, France.
Boutry-Kryza N; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Léone M; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Mazoyer S; Lyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, 69008 Lyon, France.
Bonnet-Dorion F; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Sevenet N; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Guillaud-Bataille M; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Rouleau E; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Paillerets BB; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Wappenschmidt B; Division of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, 50937 Cologne, Germany.
Rossing M; Centre for Genomic Medicine, Rigshospitalet, University of Copenhagen, 1017 Copenhagen, Denmark.
Muller D; Laboratoire d'Oncogénétique, Centre Paul Strauss, 67000 Strasbourg, France.
Bourdon V; Laboratoire d'Oncogénétique Moléculaire, Institut Paoli-Calmettes, 13009 Marseille, France.
Revillon F; Laboratoire d'Oncogénétique Moléculaire Humaine, Centre Oscar Lambret, 59000 Lille, France.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Rousselin A; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Davy G; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castelain G; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castéra L; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Sokolowska J; Service de Génétique, CHU Nancy, 54035 Nancy, France.
Coulet F; Service de génétique, Hôpital Pitié Salpétrière, AP-HP, 75013 Paris, France.
Delnatte C; Laboratoire de génétique moléculaire, CHU Nantes, 44000 Nantes, France.
Férec C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Martins A; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Krieger S; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Houdayer C; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2018 Nov 30; Vol. 46 (21), pp. 11656-11657.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies